These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 20143645

  • 1. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K, Tholanikunnel TE, Kaplan AP.
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [Abstract] [Full Text] [Related]

  • 2. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
    Joseph K, Tuscano TB, Kaplan AP.
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):279-86. PubMed ID: 18814451
    [Abstract] [Full Text] [Related]

  • 3. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP, Joseph K.
    Adv Immunol; 2014 Sep; 121():41-89. PubMed ID: 24388213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K, Kleist R, Hardt J, Witzke G.
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and treatment of hereditary angioedema.
    Canonica GW, Rossi O.
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [Abstract] [Full Text] [Related]

  • 10. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S, Levi M.
    Ann Med; 2016 Sep; 48(4):256-67. PubMed ID: 27018196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K, Tholanikunnel BG, Bygum A, Ghebrehiwet B, Kaplan AP.
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [Abstract] [Full Text] [Related]

  • 14. Bradykinin-mediated diseases.
    Kaplan AP.
    Chem Immunol Allergy; 2014 Aug; 100():140-7. PubMed ID: 24925394
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, Németh J, Cervenak L, Karádi I, Farkas H.
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M.
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.